Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Interaction of serotonergic antidepressants and opioid analgesics: Is serotonin syndrome going undetected?

Gnanadesigan N, Espinoza RT, Smith R, Israel M, Reuben DB.

J Am Med Dir Assoc. 2005 Jul-Aug;6(4):265-9.

PMID:
16005413
2.

Serotonin syndrome: is it a reason to avoid the use of tramadol with antidepressants?

Park SH, Wackernah RC, Stimmel GL.

J Pharm Pract. 2014 Feb;27(1):71-8. doi: 10.1177/0897190013504957. Epub 2013 Oct 23. Review.

PMID:
24153222
3.
4.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626
5.

Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity.

Gillman PK.

Br J Anaesth. 2005 Oct;95(4):434-41. Epub 2005 Jul 28. Review.

PMID:
16051647
6.

[Serotonin syndrome and pain medication : What is relevant for practice?].

Schenk M, Wirz S.

Schmerz. 2015 Apr;29(2):229-51. doi: 10.1007/s00482-015-1512-0. Review. German.

PMID:
25860200
7.

[Mechanism of action of new generation antidepressants under development in Japan: focusing on dopamine neurotransmission].

Nakayama K.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2009 Jun;29(3):99-108. Review. Japanese.

PMID:
19663259
8.

[Clinically significant drug-drug interactions between analgesics and psychotopics].

Strobach D.

Med Monatsschr Pharm. 2012 Jul;35(7):245-54; quiz 255-6. Review. German.

PMID:
22852275
9.

Serotonergic and adrenergic drug interactions associated with linezolid: a critical review and practical management approach.

Ramsey TD, Lau TT, Ensom MH.

Ann Pharmacother. 2013 Apr;47(4):543-60. doi: 10.1345/aph.1R604. Epub 2013 Apr 2. Review.

PMID:
23548646
10.

Serotonin syndrome. Presentation of 2 cases and review of the literature.

Mason PJ, Morris VA, Balcezak TJ.

Medicine (Baltimore). 2000 Jul;79(4):201-9. Review.

11.

A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action.

Gillman PK.

Biol Psychiatry. 2006 Jun 1;59(11):1046-51. Epub 2006 Feb 7. Review.

PMID:
16460699
12.

Overview of serotonin syndrome.

Iqbal MM, Basil MJ, Kaplan J, Iqbal MT.

Ann Clin Psychiatry. 2012 Nov;24(4):310-8. Review.

PMID:
23145389
13.

Opiates as antidepressants.

Berrocoso E, Sánchez-Blázquez P, Garzón J, Mico JA.

Curr Pharm Des. 2009;15(14):1612-22. Review.

PMID:
19442177
14.

Drug Interaction and Serotonin Toxicity with Opioid Use: Another Reason to Avoid Opioids in Headache and Migraine Treatment.

Ansari H, Kouti L.

Curr Pain Headache Rep. 2016 Aug;20(8):50. doi: 10.1007/s11916-016-0579-3. Review.

PMID:
27457368
15.

Sertraline and mirtazapine as geriatric antidepressants.

Holland J, Bhogle M.

Psychiatr Danub. 2013 Sep;25 Suppl 2:S286-90. Review.

16.

Mirtazapine: a review of its use in major depression and other psychiatric disorders.

Croom KF, Perry CM, Plosker GL.

CNS Drugs. 2009;23(5):427-52. doi: 10.2165/00023210-200923050-00006. Review.

PMID:
19453203
17.

[1+1 or 2x1? Another form of dual antidepressive mechanism of action].

Lakatos L, Rihmer Z.

Neuropsychopharmacol Hung. 2005 Sep;7(3):118-24. Review. Hungarian.

PMID:
16493875
19.

Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.

Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Repérant C, Guilloux JP, Coudoré F, Hen R, Gardier AM.

Neuropharmacology. 2008 Nov;55(6):1006-14. doi: 10.1016/j.neuropharm.2008.08.001. Epub 2008 Aug 12. Review.

PMID:
18761360
20.

[Depression and pain: novel clinical, neurobiological and psychopharmacological data].

Jaracz J, Rybakowski J.

Psychiatr Pol. 2005 Sep-Oct;39(5):937-50. Review. Polish.

PMID:
16358593

Supplemental Content

Support Center